Dr. Garcia on FDA Approval of Pembrolizumab in Bladder Cancer

Current state and future directions in bladder cancerПодробнее

EV-103 Study by Dr. Jonathan Rosenberg led to the FDA Approval of Enfortumab + PembrolizumabПодробнее

Dr. Siefker-Radtke on FDA Approval of Frontline Atezolizumab in Bladder CancerПодробнее

FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) as adjuvant treatment for ...Подробнее

Dr. Grothey on FDA Approval of Pembrolizumab in MSI-High CRCПодробнее

Dr. Petrylak on FDA Approval of Nivolumab in Bladder CancerПодробнее

Breakthrough in Bladder Cancer: FDA approval - Enfortumab Vedotin + Pelbrolizumab with Dr.Tom PowlesПодробнее

Dr. Petrylak on FDA Approval of Pembrolizumab in Bladder CancerПодробнее

Durvalumab FDA Approval for Bladder CancerПодробнее

The FDA Approval of Atezolizumab in Bladder CancerПодробнее

Dr. Steinberg on the FDA Approval of Atezolizumab in Bladder CancerПодробнее

FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) for the adjuvant treatment...Подробнее

Dr. Balar on the Approval of Pembrolizumab for Bladder CancerПодробнее

FDA Approval of Durvalumab for Advanced Bladder CancerПодробнее

Dr. Ferris on Impact of FDA Approval of Pembrolizumab in Patients With Head and Neck CancerПодробнее

FDA Approval of Durvalumab for Bladder CancerПодробнее

FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) for high-risk early-stage ...Подробнее

FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) in combination with Lenvim...Подробнее

Pembrolizumab in Newly Diagnosed Squamous NSCLCПодробнее